Physician

Ghassan Amir Atto, MD

According to 2025 Medicare claims, Ghassan Atto, MD (NPI: 1558561720) practices family practice in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is GHASSAN A ATTO MD PLLC (NPI: 1932457546; TIN: 454703805) and primary practice location at 48192-4668.

Atto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,234 traditional Medicare patients, billed 10,093 HCPCS/CPT codes, and received $588,751 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 49,708 prescription claims across 2,339 beneficiaries totaling $3,457,535 in drug costs, led by Eliquis (Apixaban). DME data shows 1,311 claims. Open Payments data shows 41 records totaling $595. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,026,048 to $588,751. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $74,988 and ending at $129,581.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,277	17,723	$1,026,048
2016	1,370	16,894	$1,050,095
2017	1,430	15,869	$1,057,569
2018	1,392	15,643	$834,119
2019	1,550	15,412	$831,677
2020	1,523	14,144	$742,339
2021	1,570	14,046	$786,608
2022	1,270	9,942	$585,976
2023	1,152	9,170	$539,998
2024	1,234	10,093	$588,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,290	41,550	$2,098,154
2016	1,416	48,269	$2,633,979
2017	1,549	52,517	$2,886,610
2018	1,667	53,264	$3,293,188
2019	1,782	45,298	$3,323,739
2020	1,763	42,855	$3,361,719
2021	1,853	40,549	$3,242,814
2022	1,915	41,691	$3,378,383
2023	2,076	41,342	$3,515,595
2024	2,339	49,708	$3,457,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	599	2,146	$78,152
2016	572	2,140	$77,930
2017	537	2,339	$82,782
2018	486	2,009	$71,929
2019	473	2,035	$149,856
2020	359	2,078	$158,475
2021	359	1,811	$84,263
2022	271	1,650	$61,883
2023	228	1,412	$66,967
2024	244	1,311	$81,400

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	472	614	$108
99497	Advance care planning, first 30 minutes	296	358	$73
99238	Hospital discharge day management, 30 minutes or less	330	417	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	407	2,239	$65
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	423	1,226	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,470	30,372	$616,221
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	360	11,632	$245,777
Jardiance	Empagliflozin	215	7,167	$143,194
Entresto	Sacubitril/Valsartan	234	5,729	$130,871
Januvia	Sitagliptin Phosphate	191	4,821	$92,821

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	48	266	$19,514
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	28	$14,774
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	14	$14,295
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	22	103	$4,488
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	14	$4,132

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$595	Neurocrine Biosciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ghassan Amir Atto, MD?

Tedicare shows public-source Medicare data for Ghassan Amir Atto, MD (NPI 1558561720), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghassan Amir Atto, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ghassan Amir Atto, MD?

Ghassan Amir Atto, MD is linked to GHASSAN A ATTO MD PLLC (billing NPI 1932457546) in the available physician profile data.

Does Ghassan Amir Atto, MD have Open Payments data?

Ghassan Amir Atto, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.